申请人:Kymera Therapeutics, Inc.
公开号:US20210002296A1
公开(公告)日:2021-01-07
The present invention provides compounds, compositions thereof, and methods of using the same for the targeted degradation of proteins, and the treatment of target protein-mediated disorders.